Literature DB >> 28986261

MMP-9-cleaved osteopontin isoform mediates tumor immune escape by inducing expansion of myeloid-derived suppressor cells.

Lijuan Shao1, Bo Zhang1, Lingxiong Wang2, Liangliang Wu2, Quancheng Kan3, Kexing Fan4.   

Abstract

As an extracellular matrix protein, osteopontin (OPN) has been shown to play an important role in regulation of the immune response to tumors. Myeloid-derived suppressor cells (MDSCs), a heterogeneous population of myeloid progenitors, are major components of the immune suppressive tumor microenvironment and contribute to tumor evasion of the immune response. However, the specific regulating mechanisms underlying MDSCs expansion remain unclear. Here, we found that MDSCs accumulated in the spleen and tumors of 3LL tumor-bearing mice. Supernatant collected from 3LL cells was able to induce the expansion of MDSCs in peripheral blood mononuclear cell (PBMC) in vitro. Results of enzyme linked immunosorbent assay showed high levels of OPN and matrix metalloproteinase-9 (MMP-9) in this supernatant. Silencing OPN can effectively reduce MDSCs frequency in vivo and in vitro. Furthermore, a specific fragment of OPN, OPN-32 kDa cleaved by MMP-9 was detected in the supernatant from 3LL cells. Overexpression of OPN-32 kDa in 3LL cells induced MDSCs expansion. Inhibition of MMP-9 by monoclonal antibody and inhibitor (TIMP-1) reduced MDSCs expansion in vitro and in vivo. These findings suggest that the MMP-9-cleaved OPN fragment, OPN-32kDa, was responsible for MDSCs expansion, which may contribute to tumor's evasion of the immune response.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Matrix metalloproteinase- 9; Myeloid-derived suppressor cell; Osteopontin; Tumor immune escape

Mesh:

Substances:

Year:  2017        PMID: 28986261     DOI: 10.1016/j.bbrc.2017.10.009

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases.

Authors:  Dipak Panigrahy; Allison Gartung; Jun Yang; Haixia Yang; Molly M Gilligan; Megan L Sulciner; Swati S Bhasin; Diane R Bielenberg; Jaimie Chang; Birgitta A Schmidt; Julia Piwowarski; Anna Fishbein; Dulce Soler-Ferran; Matthew A Sparks; Steven J Staffa; Vidula Sukhatme; Bruce D Hammock; Mark W Kieran; Sui Huang; Manoj Bhasin; Charles N Serhan; Vikas P Sukhatme
Journal:  J Clin Invest       Date:  2019-06-17       Impact factor: 14.808

Review 2.  Roles, molecular mechanisms, and signaling pathways of TMEMs in neurological diseases.

Authors:  Qinghong Chen; Junlin Fang; Hui Shen; Liping Chen; Mengying Shi; Xianbao Huang; Zhiwei Miao; Yating Gong
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  YAP1/MMP7/CXCL16 axis affects efficacy of neoadjuvant chemotherapy via tumor environment immunosuppression in triple-negative breast cancer.

Authors:  Jia-Qi Yuan; Ke-Jing Zhang; Shou-Man Wang; Lei Guo
Journal:  Gland Surg       Date:  2021-09

4.  A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma.

Authors:  Akira Ooki; Taroh Satoh; Kei Muro; Atsuo Takashima; Shigenori Kadowaki; Daisuke Sakai; Takashi Ichimura; Seiichiro Mitani; Toshihiro Kudo; Keisho Chin; Shigehisa Kitano; Dung Thai; Marianna Zavodovskaya; JieJane Liu; Narikazu Boku; Kensei Yamaguchi
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

Review 5.  Osteopontin in autoimmune disorders: current knowledge and future perspective.

Authors:  Canhua Xu; Yaohong Wu; Ning Liu
Journal:  Inflammopharmacology       Date:  2022-03-02       Impact factor: 5.093

6.  MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors.

Authors:  Vladi Juric; Chris O'Sullivan; Erin Stefanutti; Maria Kovalenko; Andrew Greenstein; Vivian Barry-Hamilton; Igor Mikaelian; Jeremiah Degenhardt; Peng Yue; Victoria Smith; Amanda Mikels-Vigdal
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

Review 7.  Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight.

Authors:  Anne-Sophie Lamort; Ioanna Giopanou; Ioannis Psallidas; Georgios T Stathopoulos
Journal:  Cells       Date:  2019-08-02       Impact factor: 6.600

8.  Extracellular Vesicles Enriched with Moonlighting Metalloproteinase Are Highly Transmissive, Pro-Tumorigenic, and Trans-Activates Cellular Communication Network Factor (CCN2/CTGF): CRISPR against Cancer.

Authors:  Yuka Okusha; Takanori Eguchi; Manh T Tran; Chiharu Sogawa; Kaya Yoshida; Mami Itagaki; Eman A Taha; Kisho Ono; Eriko Aoyama; Hirohiko Okamura; Ken-Ichi Kozaki; Stuart K Calderwood; Masaharu Takigawa; Kuniaki Okamoto
Journal:  Cancers (Basel)       Date:  2020-04-04       Impact factor: 6.639

9.  OPN Deficiency Increases the Severity of Osteoarthritis Associated with Aberrant Chondrocyte Senescence and Apoptosis and Upregulates the Expression of Osteoarthritis-Associated Genes.

Authors:  Jian Tian; Chao Cheng; Shi-Da Kuang; Chao Su; Xin Zhao; Yi-Lin Xiong; Yu-Sheng Li; Shu-Guang Gao
Journal:  Pain Res Manag       Date:  2020-10-22       Impact factor: 3.037

10.  Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.

Authors:  Youqiong Ye; Xinwei Kuang; Zuozhong Xie; Long Liang; Zhao Zhang; Yongchang Zhang; Fangyu Ma; Qian Gao; Ruimin Chang; Heng-Huan Lee; Shuang Zhao; Juan Su; Hui Li; Jingbo Peng; Huifang Chen; Minzhu Yin; Cong Peng; Nong Yang; Jing Wang; Jing Liu; Hong Liu; Leng Han; Xiang Chen
Journal:  Genome Med       Date:  2020-09-28       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.